PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Disease Reportsmastocytosis
MeSH D008415 - mastocytosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
D009372:Connective tissue neoplasms
0 Companies
0 Drugs
Success rate
D000090362:Mast cell activation disorders
0 Companies
0 Drugs
Success rate
D008415: 
Mastocytosis
$
Success rate
D012515:Mast-cell sarcoma
0 Companies
0 Drugs
Success rate
D034701:Cutaneous mastocytosis
0 Companies
0 Drugs
Success rate
D034721:Systemic mastocytosis
$
Success rate
D034801:Mastocytoma
0 Companies
0 Drugs
Success rate
Events Timeline
Loading
Commercial
Company Name
Drug Name
Trade Name
Patent Expires
Approval Date
Revenue
Period
TevaCromolyn Cromolyn  2000-01-18   
MylanCromolyn Gastrocrom  1996-02-29   
PerrigoCromolyn Cromolyn  2001-12-12   
SandozCromolyn Cromolyn  1999-06-16   
SanofiCromolyn Intal  1982-01-01   
UCBCromolyn Gastrocrom  1989-12-22   
King PharmaceuticalsCromolyn Cromoptic  1999-04-27   
Cromolyn Intal  1982-05-28   
Bausch Health CompaniesCromolyn Crolom  1995-01-30   
Cromolyn Cromolyn  2000-12-21   
AllerganCromolyn Opticrom  1984-10-03   
Cromolyn Cromolyn  2001-07-26   
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
0%
0/0
Phase 2
10%
1/10
Phase 3
67%
2/3
Approved: 2Overall Success rate: 0%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name
Phase 1
Phase 2
Phase 3
Phase 4
Drug Name
Novartis
1
2
>
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use